gip hormone tirzepatide Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research GLP1-GIP receptor co-agonists: a promising

As body weight decreases, hepatic fat content falls, reducing hepatic insulin resistance

members access to prescription weight loss drugs, including Ozempic and Wegovi

ADA guidelines recommend GLP-1 agonists as preferred second-line agents for patients with established atherosclerotic cardiovascular disease

Can venlafaxine cause a false positive for PCP

If you are unsure/on the edge for deciding whether to revascularize a patient with 25-50% LGE on CMR, you can give dobutamine and see if that portion of the LV has augmented contractility (sign of life)

Per the SUPPORT act, the updated draft guidance includes Congress changes to the definition of adverse drug experience regarding reduced effectiveness and what safety labeling changes manufacturers should include with certain products